Post-approval studies (Phase 4)Study completedNCT02584543
What this trial is testing
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)
Who this might be right for
Hepatitis EHepatitis B
Xiamen Innovax Biotech Co., Ltd 602